Selexys' sickle sale
Selexys A round by MPM comes with a Novartis option to buy hematology company
Selexys' sickle sale
MPM Capital is betting that veterans from Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) can turn the firm's investment in hematology play Selexys Pharmaceuticals Corp. into a takeout within three years.
Last week, Selexys raised $23 million in a
